Dapagliflozin: a potential lifesaver for "heart failure patients with mildly reduced or preserved ejection fraction" in the world

被引：0
|
作者：
Bijarani, Faizan Shafqat Ali [1 ]
Nazeer, Ahsan [1 ]
Shaikh, Bisma [1 ]
机构：
[1] Jinnah Sindh Med Univ, Karachi, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2023年 / 73卷 / 12期
关键词：
D O I：
10.47391/JPMA.9968
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2529 / 2529
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J., V
    Claggett, B.
    de Boer, R. A.
    DeMets, D.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F.
    Shah, S. J.
    Desai, A. S.
    Jhund, P. S.
    Belohlavek, J.
    Chiang, C-E
    Borleffs, C. J. W.
    Comin-Colet, J.
    Dobreanu, D.
    Drozdz, J.
    Fang, J. C.
    Alcocer-Gamba, M. A.
    Al Habeeb, W.
    Han, Y.
    Cabrera Honorio, J. W.
    Janssens, S. P.
    Katova, T.
    Kitakaze, M.
    Merkely, B.
    O'Meara, E.
    Saraiva, J. F. K.
    Tereshchenko, S. N.
    Thierer, J.
    Vaduganathan, M.
    Vardeny, O.
    Verma, S.
    Pham, V. N.
    Wilderang, U.
    Zaozerska, N.
    Bachus, E.
    Lindholm, D.
    Petersson, M.
    Langkilde, A. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, : 1089 - 1098
  • [2] Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
    Cunningham, Jonathan W.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Kulac, Ian J.
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    McGrath, Martina M.
    O'Meara, Eileen
    Wilderang, Ulrica
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (14) : 1302 - 1310
  • [3] Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    Selvaraj, Senthil
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Miao, Zi Michael
    Fang, James C.
    Vardeny, Orly
    Desai, Akshay S.
    Shah, Sanjiv J.
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Inzucchi, Silvio E.
    de Boer, Rudolf A.
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    JACC-HEART FAILURE, 2023, 11 (01) : 76 - 89
  • [4] Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status
    Peikert, Alexander
    Goyal, Parag
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Kulac, Ian J.
    Miao, Zi Michael
    Vardeny, Orly
    Kosiborod, Mikhail N.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Lam, Carolyn S. P.
    Inzucchi, Silvio E.
    Martinez, Felipe A.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Shah, Sanjiv J.
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J. V.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2023, 11 (10) : 1380 - 1393
  • [5] Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
    Solomon, Scott D.
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Lindholm, Daniel
    Wilderang, Ulrica
    Ohrn, Fredrik
    Claggett, Brian
    Langkilde, Anna Maria
    Petersson, Magnus
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (07) : 1217 - 1225
  • [6] Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian
    Vardeny, Orly
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Lam, Carolyn S. P.
    Kosiborod, Mikhail N.
    Shah, Sanjiv J.
    Martinez, Felipe
    Inzucchi, Silvio E.
    Hernandez, Adrian F.
    Haddad, Tariq
    Mitter, Sumeet S.
    Miao, Zi Michael
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2930 - 2943
  • [7] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [8] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Effect of dapagliflozin in patients in Asia with heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER
    Wang, X.
    Lam, C. S. P.
    Claggett, B.
    Miao, M.
    Shah, S. J.
    Jhund, P. S.
    Desai, A. S.
    Chiang, C.
    Pham, V. N.
    Han, Y.
    Kitakaze, M.
    Langkilde, A. M.
    Mcmurray, J. J. V.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [10] Effect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial
    Chatur, S.
    Vaduganathan, M.
    Claggett, B. L.
    Desai, A. S.
    Docherty, K. F.
    Jhund, P. S.
    De Boer, R. A.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F. A.
    Shah, S. J.
    Mcmurray, J. V.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2023, 44
12345